Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex

Author:

Isaac-Lam Meden F.ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference120 articles.

1. Abu-Raddad LJ, Chemaitelly H, Butt AA (2021) Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J Med 385:187–189. https://doi.org/10.1056/NEJMc2104974

2. Acharya A, Agarwal R, Baker MB, Baudry J, Bhowmik D, Boehm S, Byler KG, Chen SY, Coates L, Cooper CJ, Demerdash O, Daidone I, Eblen JD, Ellingson S, Forli S, Glaser J, Gumbart JC, Gunnels J, Hernandez O, Irle S, Kneller DW, Kovalevsky A, Larkin J, Lawrence TJ, LeGrand S, Liu SH, Mitchell JC, Park G, Parks JM, Pavlova A, Petridis L, Poole D, Pouchard L, Ramanathan A, Rogers DM, Santos-Martins D, Scheinberg A, Sedova A, Shen Y, Smith JC, Smith MD, Soto C, Tsaris A, Thavappiragasam M, Tillack AF, Vermaas JV, Vuong VQ, Yin J, Yoo S, Zahran M, Zanetti-Polzi L (2020) Supercomputer-based ensemble docking drug discovery pipeline with application to Covid-19. J Chem Inf Model 60(12):5832–5852. https://doi.org/10.1021/acs.jcim.0c01010

3. Akachar J, Bouricha EM, Hakmi M, Belyamani L, Jaoudi RE, Ibrahimi A (2020) Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach. Heliyon 6(12):e05739. https://doi.org/10.1016/j.heliyon.2020.e05739

4. Aleem A, Akbar Samad AB, Slenker AK (2021) Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). 2021. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island

5. Aleksova A, Gagno G, Sinagra G, Beltrami AP, Janjusevic M, Ippolito G, Zumla A, Fluca AL, Ferro F (2021) Effects of SARS-CoV-2 on cardiovascular system: the dual role of angiotensin-converting enzyme 2 (ACE2) as the virus receptor and homeostasis regulator-review. Int J Mol Sci 22(9):4526. https://doi.org/10.3390/ijms22094526

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3